Second, we tested whether DNA‐PK is responsible for type I IFN responses in the absence of cGAS in glioblastoma cells by treating T98G, Gli4, and GSC9 with the NU7441 DNA‐PKcs inhibitor. Here, PRKDC is linked to glioblastoma.